Elevai Labs (ELAB) News Today $1.64 +0.02 (+0.92%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.65 +0.00 (+0.24%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period PMGC files to sell 969,386 shares of common stock for holdersFebruary 12, 2025 | markets.businessinsider.comNorthstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1February 4, 2025 | globenewswire.comPMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology CompaniesJanuary 31, 2025 | globenewswire.comPMGC Holdings announces equity sale through warrant inducementJanuary 29, 2025 | msn.comUnivest Securities, LLC Announces Closing of $1.92 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)January 28, 2025 | globenewswire.comElevai Labs stock hits 52-week low at $1.74 amid steep annual declineJanuary 28, 2025 | msn.comPMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional InvestorsJanuary 27, 2025 | globenewswire.comPMGC Stock Surges On Invitation To Present ‘Probiotic’ For Preventing Muscle Loss: Retail Chatter SpikesJanuary 27, 2025 | msn.comNorthstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity SymposiumJanuary 24, 2025 | globenewswire.comPMGC Holdings meets Nasdaq compliance; subsidiaries rebrandJanuary 17, 2025 | msn.comPMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture to Carmell CorporationJanuary 17, 2025 | finanznachrichten.dePMGC Holdings announces name change of wholly owned subsidiaresJanuary 16, 2025 | markets.businessinsider.comPMGC Holdings Inc. Announces Closing of Elevai Skincare DivestitureJanuary 16, 2025 | globenewswire.comPMGC Holdings Inc. Announces Name Change of Wholly Owned SubsidiariesJanuary 15, 2025 | globenewswire.comPMGC Holdings Inc (ELAB)January 4, 2025 | investing.comPMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth StrategyJanuary 2, 2025 | globenewswire.comCarmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care ProductsJanuary 2, 2025 | globenewswire.com2025 Startups to Watch: Elevai Labs Inc.January 2, 2025 | bizjournals.comElevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to NevadaDecember 20, 2024 | globenewswire.comElevai Labs plans name change to PMGC Holdings, redomicile to NevadaDecember 20, 2024 | markets.businessinsider.comElevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to NevadaDecember 20, 2024 | globenewswire.comElevai Labs subsidiary announces FDA regulatory pathway for EL-22December 10, 2024 | markets.businessinsider.comElevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care MarketDecember 6, 2024 | globenewswire.comElevai Labs subsidiary achieved record-breaking month in sales for 2024December 4, 2024 | markets.businessinsider.comElevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare DivisionDecember 4, 2024 | finance.yahoo.comElevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to ReassessNovember 23, 2024 | finance.yahoo.comElevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing ComplianceNovember 22, 2024 | globenewswire.comElevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to ReassessNovember 22, 2024 | globenewswire.comCORRECTION - Elevai Labs Inc.November 14, 2024 | globenewswire.comElevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business UpdateNovember 14, 2024 | globenewswire.comElevai Labs Inc. Announces Update and Extension of Pending Offer to ExchangeNovember 4, 2024 | markets.businessinsider.comElevai Labs Inc. Announces Update and Extension of Pending Offer to ExchangeNovember 4, 2024 | globenewswire.comElevai Biosciences highlights past preclinical data on EL-32October 22, 2024 | markets.businessinsider.comElevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of ObesityOctober 22, 2024 | globenewswire.comElevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of ObesityOctober 21, 2024 | globenewswire.comElevai Labs commences exosome skincare studyOctober 4, 2024 | uk.investing.comElevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred StockOctober 4, 2024 | globenewswire.comREPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist CombinationsOctober 3, 2024 | globenewswire.comElevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist CombinationsOctober 3, 2024 | globenewswire.comElevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy DeviceOctober 2, 2024 | globenewswire.comElevai Labs (NASDAQ:ELAB) Stock, Short Interest ReportOctober 1, 2024 | benzinga.comElevai Labs stock offering raises $8 millionSeptember 27, 2024 | bizjournals.comAltium Capital Management LP Acquires New Stake in Elevai Labs IncSeptember 27, 2024 | finance.yahoo.comUnivest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB)September 24, 2024 | globenewswire.comElevai Labs shares tumble on pricing of new stock offeringSeptember 24, 2024 | bizjournals.comDow Gains Over 50 Points; Elevai Labs Shares PlummetSeptember 23, 2024 | benzinga.comWhy Elevai Labs (ELAB) Stock Is Down 60% TodaySeptember 23, 2024 | msn.comElevai Labs Inc. Announces Pricing of $8.0 Million Public OfferingSeptember 23, 2024 | globenewswire.comElevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma ApplicationsSeptember 10, 2024 | globenewswire.comElevai Labs files for 25M stock offeringSeptember 6, 2024 | msn.com Get Elevai Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter. Email Address ELAB Media Mentions By Week ELAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELAB News Sentiment▼0.000.78▲Average Multi-Sector Conglomerates News Sentiment ELAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELAB Articles This Week▼01▲ELAB Articles Average Week Get Elevai Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CARM News LPCN News APRE News LPTX News MIRA News OKUR News COCP News NNVC News GLYC News MRKR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELAB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevai Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevai Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
